Cutanogen Appoints Richard Kagan, MD as Chief Medical Advisor
April 23, 2018 08:00 ET
|
Amarantus Bioscience Holdings, Inc.
NEW YORK, April 23, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Cutanogen Corporation, an orphan clinical-stage regenerative medicine wholly-owned subsidiary of Amarantus Bioscience Holdings, Inc....